{
"ProductData": {
"RelatedLinks": "",
"RegulatoryDisclaimer1": "For further processing only.",
"RegulatoryDisclaimer2": "",
"StainLocalization": [
""
],
"ProductType": "Others",
"DisclaimerGroup2": null,
"ProductNameGlobal": "Neuraminidase exo-alpha-Sialidase",
"DisclaimerGroup1": "",
"ControlTissue": [
""
],
"BrandName": "Neuraminidase (exo-α-Sialidase)",
"LicenseDisclaimers": [
{
"Order": "78",
"Identifier": "1403506419168",
"LongText": "The sale of the Product does not exhaust or grant any rights in third party patents including patents of companies of the F. Hoffmann - La Roche AG group of companies, in particular, for the use of modified antibodies obtained by using the product."
}
],
"Isotypes": "",
"RegulatoryDisclaimer3": "",
"ID": "3.1.1.2.20.1",
"ProductNameAddition": "from
Vibrio cholerae, solution",
"Species": [
""
],
"Clone": ""
},
"ProductImageDetails": {
"ImagePath": "https://pim-media.roche.com/Images/CB_IMAGE.png",
"ImageType": "Image main"
},
"Product2Taxomony": {
"Product2TaxomonyReferences": [
{
"StructureSystemIdentifier": "OWP_Product_Types",
"StructureSystemName": "Product Types",
"NodeName": "Glycosidases",
"NodeID": "70-024-00"
},
{
"StructureSystemIdentifier": "Product_Grouping",
"StructureSystemName": "Product Grouping",
"NodeName": "In vitro Glycoengineering",
"NodeID": "02-0052"
},
{
"StructureSystemIdentifier": "OWP_Organization",
"StructureSystemName": "Organization",
"NodeName": "CustomBiotech and LifeScience",
"NodeID": "01-01-01-07-00"
},
{
"StructureSystemIdentifier": "Product_Grouping",
"StructureSystemName": "Product Grouping",
"NodeName": "Enzymes",
"NodeID": "02-0014"
},
{
"StructureSystemIdentifier": "Product_Solutions",
"StructureSystemName": "Product Solutions",
"NodeName": "CustomBiotech",
"NodeID": "520"
},
{
"StructureSystemIdentifier": "Lab_Type",
"StructureSystemName": "Lab Types",
"NodeName": "Manufacturing",
"NodeID": "180-00"
},
{
"StructureSystemIdentifier": "Applications",
"StructureSystemName": "Applications",
"NodeName": "NOT APPLICABLE",
"NodeID": "99-00-00"
},
{
"StructureSystemIdentifier": "OWP_Techniques",
"StructureSystemName": "Techniques",
"NodeName": "NOT APPLICABLE",
"NodeID": "999-00"
},
{
"StructureSystemIdentifier": "Disease_Areas",
"StructureSystemName": "Disease Areas",
"NodeName": "NOT APPLICABLE",
"NodeID": "99-00-00"
},
{
"StructureSystemIdentifier": "Pathogens",
"StructureSystemName": "Pathogens",
"NodeName": "NOT APPLICABLE",
"NodeID": "99-00-00"
},
{
"StructureSystemIdentifier": "OWP_Family",
"StructureSystemName": "Product Families",
"NodeName": "NOT APPLICABLE",
"NodeID": "999"
},
{
"StructureSystemIdentifier": "Health_Topics",
"StructureSystemName": "Health Topics",
"NodeName": "NOT APPLICABLE",
"NodeID": "99-00-00"
}
]
},
"Product2Taxonomy": {
"Product2TaxonomyReferences": [
{
"StructureSystemIdentifier": "OWP_Product_Types",
"StructureSystemName": "Product Types",
"NodeName": "Glycosidases",
"NodeID": "70-024-00"
},
{
"StructureSystemIdentifier": "Product_Grouping",
"StructureSystemName": "Product Grouping",
"NodeName": "In vitro Glycoengineering",
"NodeID": "02-0052"
},
{
"StructureSystemIdentifier": "OWP_Organization",
"StructureSystemName": "Organization",
"NodeName": "CustomBiotech and LifeScience",
"NodeID": "01-01-01-07-00"
},
{
"StructureSystemIdentifier": "Product_Grouping",
"StructureSystemName": "Product Grouping",
"NodeName": "Enzymes",
"NodeID": "02-0014"
},
{
"StructureSystemIdentifier": "Product_Solutions",
"StructureSystemName": "Product Solutions",
"NodeName": "CustomBiotech",
"NodeID": "520"
},
{
"StructureSystemIdentifier": "Lab_Type",
"StructureSystemName": "Lab Types",
"NodeName": "Manufacturing",
"NodeID": "180-00"
},
{
"StructureSystemIdentifier": "Applications",
"StructureSystemName": "Applications",
"NodeName": "NOT APPLICABLE",
"NodeID": "99-00-00"
},
{
"StructureSystemIdentifier": "OWP_Techniques",
"StructureSystemName": "Techniques",
"NodeName": "NOT APPLICABLE",
"NodeID": "999-00"
},
{
"StructureSystemIdentifier": "Disease_Areas",
"StructureSystemName": "Disease Areas",
"NodeName": "NOT APPLICABLE",
"NodeID": "99-00-00"
},
{
"StructureSystemIdentifier": "Pathogens",
"StructureSystemName": "Pathogens",
"NodeName": "NOT APPLICABLE",
"NodeID": "99-00-00"
},
{
"StructureSystemIdentifier": "OWP_Family",
"StructureSystemName": "Product Families",
"NodeName": "NOT APPLICABLE",
"NodeID": "999"
},
{
"StructureSystemIdentifier": "Health_Topics",
"StructureSystemName": "Health Topics",
"NodeName": "NOT APPLICABLE",
"NodeID": "99-00-00"
}
]
},
"Product2Materials": {
"P2MaterialReferences": [
{
"MaterialNum": "11087096103",
"MaterialDescription": "Neuraminidase (Sialidase)",
"RegisteredProductName": "Neuraminidase (exo-alpha-Sialidase)",
"GTIN": "",
"ProductCategoryText": "Reagents, kits",
"OldMaterialNumber": "",
"PackSizePIM360": "custom fill",
"PackSizeDescPIM360": "",
"MaterialAnnotation": "CustomBiotech product. Please contact your
local representative.",
"ReadyForUse": "",
"OrderInformation": "Will be supplied as \"Neuraminidase (Sialidase)\". Unit of measure is \"U\"."
}
]
},
"Product2Products": {
"Product2ProductReference": [
]
},
"ProductSpec": [
{
"ProductSpecVariant": {
"Chapters": [
{
"Language": "en",
"Value": "Neuraminidase hydrolyzes terminal N- or O-acetylneuraminic acids which are α2,3-, α2,6-, α2,8- linked to oligosaccharides, polysaccharides, mucopolysaccharides, glycoproteins, and glycolipids. For the hydrolysis of glycolipids, the presence of a detergent is necessary. Roche's Neuraminidase is very well suited for structural research studies on glycoconjugates and for hydrolytic cleavage of sialic acid from biological material.",
"Country": "XG",
"Code": "Applications",
"Name": "Applications"
},
{
"Language": "en",
"Value": "Will be supplied as \"Neuraminidase (Sialidase)\". Unit of measure is \"U\".",
"Country": "XG",
"Code": "CB - Order Information",
"Name": "CB - Order Information"
},
{
"Language": "en",
"Value": "Neuraminidase is a glycohydrolase.",
"Country": "XG",
"Code": "Positioning",
"Name": "Positioning"
},
{
"Language": "en",
"Value": "Neuraminidase hydrolyzes terminal N- or O-acyl-neuraminic acids that are α2,3-, α2,6-, or α2,8-linked to galactose, Hex, NAc, or N- or O-acylated neuraminyl residues in oligosaccharides/glycoconjugates or colominic acid. Relative rate of cleavage is α2→3 >α2→6 >α2→8, determined on bonds in tri- and tetrasaccharides.",
"Country": "XG",
"Code": "Product Description",
"Name": "Product Description"
},
{
"Language": "en",
"Value": "
CAS Number: 9001-67-6
Molecular weight: Approximately 95 kD
pH optimum: 5.5-6.2
Specific activity: Approximately 20 U/mg total protein (approximately 40 U/mg enzyme protein at +37°C) and pH 5.5 with N-acetyl-neuraminosyl-D-lactose as the substrate.",
"Country": "XG",
"Code": "Properties",
"Name": "Properties"
},
{
"Language": "en",
"Value": "
Appearance: Clear, colorless solution
Contents (after blending with Micr-O-protect
® and EDTA): Natrium acetate, 50 mmol/L; NaCl, 154 mmol/L; CaCl
2, 9 mmol/L; EDTA, 10 mmol/L; Micr-O-protect
® 0.1% (w/v)
pH value: 5.0-6.0
Activity (+37°C, with N-acetylneuraminyl-lactose): ≥1.0 U/mL
Stability: At +2 to +8°C within specification range for 18 months.",
"Country": "XG",
"Code": "Specification",
"Name": "Specification"
}
]
}
}
]
}